Methylprednisolone Active Not Recruiting Phase 3 Trials for Scleroderma, Systemic / Scleroderma Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01445821Autologous Stem Cell Systemic Sclerosis Immune Suppression Trial